Bellicum Pharmaceuticals (BLCM) Revenue & Revenue Breakdown
Bellicum Pharmaceuticals Revenue Highlights
Latest Revenue (Y)
$1.50M
Latest Revenue (Q)
$1.00M
Main Segment (Y)
License Revenue
Bellicum Pharmaceuticals Revenue by Period
Bellicum Pharmaceuticals Revenue by Year
| Date | Revenue | Change |
|---|---|---|
| 2022-12-31 | $1.50M | -75.81% |
| 2021-12-31 | $6.20M | 1140.00% |
| 2020-12-31 | $500.00K | -93.00% |
| 2019-12-31 | $7.14M | 537.77% |
| 2018-12-31 | $1.12M | 505.41% |
| 2017-12-31 | $185.00K | -52.32% |
| 2016-12-31 | $388.00K | 37.59% |
| 2015-12-31 | $282.00K | -84.16% |
| 2014-12-31 | $1.78M | -8.28% |
| 2013-12-31 | $1.94M | 31.99% |
| 2012-12-31 | $1.47M | - |
Bellicum Pharmaceuticals generated $1.50M in revenue during NA 2022, up -75.81% compared to the previous quarter, and up 810.81% compared to the same period a year ago.
Bellicum Pharmaceuticals Revenue by Quarter
| Date | Revenue | Change |
|---|---|---|
| 2023-09-30 | $1.00M | 100.00% |
| 2023-06-30 | - | -100.00% |
| 2023-03-31 | $8.00K | -98.40% |
| 2022-12-31 | $500.00K | -50.00% |
| 2022-09-30 | $1.00M | 100.00% |
| 2022-06-30 | - | 100.00% |
| 2022-03-31 | - | -100.00% |
| 2021-12-31 | $500.00K | -90.00% |
| 2021-09-30 | $5.00M | 614.29% |
| 2021-06-30 | $700.00K | 100.00% |
| 2021-03-31 | - | -100.00% |
| 2020-12-31 | $500.00K | 100.00% |
| 2020-09-30 | - | 100.00% |
| 2020-06-30 | - | 100.00% |
| 2020-03-31 | - | -100.00% |
| 2019-12-31 | $5.13M | 4883.50% |
| 2019-09-30 | $103.00K | -92.60% |
| 2019-06-30 | $1.39M | 169.57% |
| 2019-03-31 | $516.00K | 65.38% |
| 2018-12-31 | $312.00K | 6.85% |
| 2018-09-30 | $292.00K | -19.34% |
| 2018-06-30 | $362.00K | 135.06% |
| 2018-03-31 | $154.00K | -323.19% |
| 2017-12-31 | $-69.00K | -154.76% |
| 2017-09-30 | $126.00K | 100.00% |
| 2017-06-30 | - | -100.00% |
| 2017-03-31 | $128.00K | 58.02% |
| 2016-12-31 | $81.00K | -28.95% |
| 2016-09-30 | $114.00K | 12.87% |
| 2016-06-30 | $101.00K | 9.78% |
| 2016-03-31 | $92.00K | 170.59% |
| 2015-12-31 | $34.00K | -40.35% |
| 2015-09-30 | $57.00K | -32.14% |
| 2015-06-30 | $84.00K | -21.50% |
| 2015-03-31 | $107.00K | 613.24% |
| 2014-12-31 | $15.00K | -97.73% |
| 2014-09-30 | $660.00K | 19.13% |
| 2014-06-30 | $554.00K | 0.36% |
| 2014-03-31 | $552.00K | -32.60% |
| 2013-12-31 | $818.96K | - |
Bellicum Pharmaceuticals generated $1.00M in revenue during Q3 2023, up 100.00% compared to the previous quarter, and up Infinity% compared to the same period a year ago.
Bellicum Pharmaceuticals Revenue Breakdown
Bellicum Pharmaceuticals Revenue Breakdown by Product
Annual Revenue by Product
| Product/Service | Dec 22 | Dec 21 | Dec 20 | Dec 19 |
|---|---|---|---|---|
| License Revenue | $1.50M | $5.50M | - | - |
| Supply Agreement | - | $700.00K | - | - |
| Supply Agreement And License Revenue | - | $6.20M | - | - |
| License | - | - | $500.00K | $5.00M |
Bellicum Pharmaceuticals's latest annual revenue breakdown by segment (product or service), as of Dec 22: License Revenue (100.00%).
Quarterly Revenue by Product
| Product/Service | Sep 23 | Sep 22 | Dec 21 | Sep 21 | Jun 21 | Dec 19 |
|---|---|---|---|---|---|---|
| Supply Agreement | - | - | - | - | - | - |
| License | $1.00M | $1.00M | $5.00M | - | - | - |
| License Revenue | - | - | $500.00K | $5.00M | - | - |
| Grant | - | - | - | - | $700.00K | - |
Bellicum Pharmaceuticals's latest quarterly revenue breakdown by segment (product or service), as of Sep 23: License (100.00%).
Bellicum Pharmaceuticals Peer Comparison by Revenue
BLCM Revenue FAQ
What is Bellicum Pharmaceuticals’s yearly revenue?
Bellicum Pharmaceuticals's yearly revenue for 2022 was $1.5M, representing a decrease of -75.81% compared to 2021. The company's yearly revenue for 2021 was $6.2M, representing an increase of 1140.00% compared to 2020. BLCM's yearly revenue for 2020 was $500K, representing a decrease of -93.00% compared to 2019.
What is Bellicum Pharmaceuticals’s quarterly revenue?
Bellicum Pharmaceuticals's quarterly revenue for Q3 2023 was $1M, a 100.00% increase from the previous quarter (Q2 2023), and a 0% increase year-over-year (Q3 2022). The company's quarterly revenue for Q2 2023 was $0, a -100.00% decrease from the previous quarter (Q1 2023), and a 0% increase year-over-year (Q2 2022). BLCM's quarterly revenue for Q1 2023 was $8K, a -98.40% decrease from the previous quarter (Q4 2022), and a 0% increase year-over-year (Q1 2022).
What is Bellicum Pharmaceuticals’s revenue growth rate?
Bellicum Pharmaceuticals's revenue growth rate for the last 3 years (2020-2022) was 200.00%, and for the last 5 years (2018-2022) was 33.93%.
What are Bellicum Pharmaceuticals’s revenue streams?
Bellicum Pharmaceuticals's revenue streams in c 22 are License Revenue
What is Bellicum Pharmaceuticals’s main source of revenue?
For the fiscal year ending Dec 22, the largest source of revenue of Bellicum Pharmaceuticals was License Revenue. This segment made a revenue of $1.5M, representing 100.00% of the company's total revenue.